Hospital group invests $20M in stem cell therapy biotech – FierceBiotech
Xconomy |
Hospital group invests $20M in stem cell therapy biotech
FierceBiotech Hospital group Sanford Health has invested $20 million in InGeneron to support clinical trials of a stem cell regenerative medicine. The Series D gives Sanford a financial stake in an adipose-derived stem cell therapy it is testing in a clinical trial … InGeneron Completes Strategic Financing from Sanford Health to Advance Regenerative Cell Therapies |
